ProCE Banner Activity

My Take on RA Data From APLAR, JCR, and EULAR 2019

Conference Coverage
Clinical Thought
Here’s how data from 2019 RA meetings will affect my practice.

Released: July 23, 2019

Expiration: July 21, 2020

Share

Faculty

Leonard H. Calabrese

Leonard H. Calabrese, DO

Professor of Medicine
Department of Rheumatology
Cleveland Clinic
Cleveland, Ohio

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead

Lilly

Sanofi Genzyme and Regeneron Pharmaceuticals

Faculty Disclosure

Primary Author

Leonard H. Calabrese, DO

Professor of Medicine
Department of Rheumatology
Cleveland Clinic
Cleveland, Ohio

Leonard H. Calabrese, DO, has disclosed that he has received consulting fees from AbbVie, Amgen, Bristol-Myers Squibb, Crescendo, GenPharma, Gilead Sciences, GlaxoSmithKline, Horizon, Janssen, Lilly, Pfizer, Sanofi, and Union Chimique Belge and fees for non-CME/CE services from Bristol-Myers Squibb, GenPharma, Horizon, Janssen, Sanofi, and Union Chimique Belge.